Delivery Order HSHQDC10D00025-HSHQDC14J00049

<p>This is a Definitive Contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to GlaxoSmithKline Holdings (Americas) Inc. on September 30, 2009. The contract is for the purchase of the antiviral drug Relenza for the Strategic National Stockpile, with a ceiling value of $195,479,999.40 and a firm fixed price. The contract has no set-aside designation and is scheduled for completion on September 29, 2011.</p>

This federal contract award to Glaxosmithkline, LLC, doing business as Glaxosmithkline, is for the acquisition and stockpiling of 277,632 packages of the antiviral medication Relenza (zanamivir) over a 12-month period. The $7,287,840.00 fixed-price delivery order was issued by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the U.S. Department of Health and Human Services. The contract supports disease prevention and preparedness efforts, with no...

This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company, for the supply of RELENZA 5MG DISKHALER (NDC: 00173-0681-22). The contract has a potential value of $120,537.60 and a completion date of March 30, 2023. This award is not set-aside and appears to be part of the VA's broader efforts to procure pharmaceutical products and vaccines for its healthcare services....

The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $8,712,138.75 firm fixed price delivery order to Glaxosmithkline, LLC for the supply of RELENZA (ZANAMIVIR) ROTADISK. This award is not associated with a set-aside program. Glaxosmithkline is a pharmaceutical company that provides a range of products to federal agencies, including influenza vaccines, COVID-19 treatments, and other antiviral medications. This contract...

This is a federal contract award to Glaxosmithkline, LLC by the U.S. Department of Homeland Security (DHS) for the acquisition of the antiviral medication Relenza to be included in the DHS antiviral stockpile. The contract has a ceiling value of $334,488 and is a firm fixed price delivery order. There is no set-aside designation for this award. Glaxosmithkline is a pharmaceutical company that provides a range of vaccines, antivirals, and other medical products to various U.S. government agencies...

This federal contract award to Glaxosmithkline, LLC (doing business as Glaxosmithkline) is for the purchase of 7,617 courses of the antiviral medication Zanamir (Relenza) at a firm fixed price of $17.37 per course, totaling $132,307.29. The award is from the Department of Homeland Security Countering Weapons of Mass Destruction program, with delivery required by October 31, 2018. The contract does not have a set-aside designation. Glaxosmithkline is a pharmaceutical company that provides a range...

The Defense Logistics Agency Troop Support Medical awarded Glaxosmithkline, LLC a $21,000 firm fixed price delivery order for 8509426259, Zanamivir for Inhalation. The place of performance is Research Triangle Park, North Carolina and the period of performance runs through April 17, 2023. No set-aside designation was used for this contract action. Glaxosmithkline will deliver the inhaled antiviral drug Zanamivir to the agency, likely in support of stockpiling efforts to prepare for potential...

This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline, a foreign-owned, for-profit pharmaceutical company. The contract is for the supply of zanamivir, an antiviral medication, with a potential value of $162,184.00. The contract does not have a set-aside designation and the place of performance is Research Triangle Park, North Carolina. Glaxosmithkline has provided a...

This is a $541,800.00 firm fixed price delivery order awarded to Glaxosmithkline, LLC by the Defense Logistics Agency Troop Support Medical for the supply of the antiviral medication zanamivir. The contract has a performance period ending on March 18, 2024. Glaxosmithkline, a foreign-owned pharmaceutical firm, is the prime contractor and has provided a range of medical countermeasures like vaccines and antivirals to U.S. government agencies through both contracts and grants in the past. This...

Glaxosmithkline, LLC was awarded a $26,250 firm fixed price delivery order against an unidentified contract vehicle to provide 8509423643, which is understood to be Zanamivir for inhalation, to the Defense Logistics Agency Troop Support Medical. Performance will occur in Research Triangle Park, North Carolina, with all work required to be completed by April 17, 2023. No set-aside provisions were applied to this award to supply the influenza antiviral medication to the agency, which supports...